(Q40627588)
Statements
Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancer (English)
Portielje JE
Kruit WH
Schuler M
Beck J
Lamers CH
Stoter G
Huber C
de Boer-Dennert M
Rakhit A
Bolhuis RL